Clinical Outcomes Research
Our unique position in the outpatient infusion management setting, in collaboration with our physician partners, gives us unprecedented access to the highest quality real-world clinical data.
Our data warehouse is the largest in the outpatient infusion industry
Our data sets go way beyond simple claims data and provide evidence-based research in areas such as drug utilization, clinical outcomes and disease response, safety, health economic impacts, and persistence. The strength of our data allows us to collaborate with manufacturers and physicians to study novel therapies, compare treatment sites, and other cutting-edge research.
Clinical Outcomes
Cost Savings & Lower Resource Utilization
New Therapies and Programs
Persistance
Special Populations
Here is an example of one of our class-leading studies enabled by our data:
Infection Incidence and Utilization of Antimicrobials in Physician Office Infusion Centers (POICs)
Lucinda J. Van Anglen, PharmD - Healix Infusion Therapy, Sugar Land, TX Thomas C. Hardin, PharmD - Healix Infusion Therapy, Sugar Land, TX Claudia P. Schroeder, PharmD, PhD - Healix Infusion Therapy, Sugar Land, TX View Poster
Incidence of Central Venous Catheter (CVC) Infections in Patients Treated with Intravenous Antibiotics (IVAB) in the Physician Office Infusion Center (POIC)
Authors: Barry Statner, MD - Mazur, Statner, Dutta, Nathan, PC, Thousand Oaks, CA Brenda Parker, RN, BSN - Healix Infusion Therapy, Inc., Sugar Land, TX Jennifer L. Christensen, PharmD, BCPS - Healix Infusion Therapy, Inc., Sugar Land, TX View...
Outcomes and Readmissions of Bacteremia, Endocarditis and Osteomyelitis among Patients Treated with Outpatient Parenteral Antimicrobial Therapy (OPAT) in Infectious Disease Physician Office Infusion Centers (POIC)
Authors: Michael P. Dailey, MD - Infectious Disease Services of Georgia, Roswell, GA, Richard C. Prokesch, MD - Infectious Diseases Associates, Riverdale, GA John S. Adams, MD - Knoxville Infectious Disease Consultants, PC, Knoxville, TN Lucinda J. Van Anglen,...
Clostridium difficile Associated Diarrhea Incidence and Outcomes for Patients Treated with Intravenous Antibiotics in Infectious Disease Physician Office Infusion Centers
Authors: Ramesh V. Nathan, MD - Mazur, Statner, Dutta, Nathan, PC, Thousand Oaks, CA Jorge R. Bernett, MD - Infectious Disease Doctors Medical Group, Walnut Creek, CA Andrew H. Krinsky, MD -Infectious Diseases Associates, Sarasota, FL Lucinda J. Van Anglen, PharmD...
Successful, Cost-Saving OPAT Therapy Initiated in a Physician Office Infusion Center (POIC) for Treatment of Osteomyelitis and Complicated Skin and Skin Structure Infections, a 3-Year Analysis
Authors: Richard C. Prokesch, MD, FACP, FIDSA,-Infectious Diseases Associates, P.C., Riverdale, GA Lucinda J. Van Anglen, PharmD - Healix Infusion Therapy, Inc., Sugar Land, TX Thuy N. Sixt, PharmD - Healix Infusion Therapy, Inc., Sugar Land, TX View...
Outpatient Parenteral Antibiotic Therapy (OPAT) with Telavancin: A Multi-Center Experience
Authors: Robin H. Dretler, MD - Infectious Disease Specialists of Atlanta, Atlanta, GA John S. Adams, MD - Knoxville Infectious Disease Consultants, PC, Knoxville, TN Michael P. Dailey, MD - Infectious Disease Services of Georgia, Roswell, GA Lucinda J. Van Anglen,...
Clinical Success Demonstrated in Treatment of Complicated Genitourinary Gram Negative Infections in a Physician Office Infusion Center (POIC)
Authors: Andrew H. Krinsky, MD -Infectious Disease Associates, Sarasota, FL Jorge R. Bernett, MD, - Infectious Disease Doctors Medical Group, Walnut Creek, CA Michael P. Dailey, MD - Infectious Disease Services of GA, Roswell, GA Richard C. Prokesch, MD, FACP,...
Successful Treatment of Complicated Gram Negative Sinopulmonary Infections Treated in Infectious Disease (ID) Physician Office Infusion Centers (POICs)
Authors: Ramesh V. Nathan, MD- Mazur, Statner, Dutta, Nathan, PC, Thousand Oaks, CA Curtis J. FitzSimmons, MD - Plaza Infectious Disease, Kansas City, MO John S. Adams, MD, -Knoxville Infectious Disease Consultants, PC, Knoxville, TN Alfred E. Bacon, III, MD-...
Infection Control Enhancements through Successful Implementation of United States Pharmacopeia Chapter Standards (USP 797) in a Physician Infusion Center Pharmacy
Authors: John S. Adams, MD - Knoxville Infectious Disease Consultants (KIDC), Knoxville, TN K. Dale Hooker, PharmD - Healix Infusion Therapy, Inc., Sugar Land, TX View...
Safety, Efficacy and Cost-Benefit of Initiating Treatment of Osteomyelitis and Complicated Skin and Skin Structure Infections in a Physician Office-Based Infusion Center, A Two-Year Review
Authors: Richard C. Prokesch, MD, FACP, FIDSA -Infectious Disease Associates, P.C., Riverdale, GA Maureen K. Strong, PharmD - Healix Infusion Therapy, Inc., Sugar Land, TX Lucinda J. Van Anglen, PharmD - Healix Infusion Therapy, Inc., Sugar Land, TX View...
Treatment of Osteomyelitis in Infectious Disease Physician-Operated Infusion Centers (POICs)
Authors: Jorge R. Bernett, MD, - Infectious Disease Doctors Medical Group, Walnut Creek, CA Curtis J. FitzSimmons, MD,- Plaza Infectious Diseases, Kansas City, MO Lucinda J. Van Anglen, PharmD, - Healix Infusion Therapy, Inc., Sugar Land, TX Kimberly A. Couch,...
Safety and Efficacy of Direct Physician Office-Based Infusion Center (POIC) Admissions for Antibiotic Treatment of Osteomyelitis (OSTEO) and Complicated Skin and Skin Structure Infections (cSSSI)
Authors: Richard C. Prokesch, MD, FACP, FIDSA -Infectious Disease Associates, P.C., Riverdale, GA Maureen K. Strong, PharmD - Healix Infusion Therapy, Inc., Sugar Land, TX Lucinda J. Van Anglen, PharmD - Healix Infusion Therapy, Inc., Sugar Land, TX View...
Parenteral Antimicrobial Therapy Initiated in the Infectious Disease (ID) Physician Office: What and Why?
Authors: Kimberly A. Couch, PharmD, MA, FIDSA, - Healix Infusion Therapy, Inc., Sugar Land, TX Lucinda J. Van Anglen, PharmD, - Healix Infusion Therapy, Inc., Sugar Land, TX Alfred E. Bacon III, MD - Infectious Disease Associates, P.A., Newark, DE View...
Phase II and Phase III Studies
Healix regularly and actively supports Phase II and Phase III clinical trials in each of our specialty areas, including active studies in Multiple Sclerosis and Intestinal Bowel Disease.
For information on partnering with Healix on a study, please contact us.